FYR lands funding to find new biomarkers for Parkinson’s and beyond

Expanding from oncology into neurodegeneration, company leverages tiny extracellular vesicles to enhance blood-based biomarker discovery. Precision medicine biotech FYR Bio has closed an $8 million financing round to accelerate its expansion into neurodegenerative disease research, extending the com…